Pre recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT[...]
Spero Therapeutics Announces Third Quarter 2024 Operating Results and[...]
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and[...]
11/14/2024 | Press release | Distributed by Public on 11/14/2024 08:22
Please select the service you want to use:
Smartlinks | Arrowhead Pharmaceuticals Inc. | News | Health | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Pharmaceuticals | Securities Issuers | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Bolsa Institucional de Valores (BIVA) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact